Daniel J. Lenihan et al. BTS 2016;1:

Slides:

Advertisements

Similar presentations

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Advertisements

Figure 2. Effect of Siberian and Panax ginseng respectively on postprandial glucose level before and after three months of intake in patients with type.

Trial profile for the pharmacokinetics and pharmacodynamics study in patients with dyslipidaemia (A) and the ambulatory blood pressure study (B) *Participants.

Copyright © 2003 American Medical Association. All rights reserved.

Selecting Appropriate Dose Regimens for AM-101 in the Intratympanic Treatment of Acute Inner Ear Tinnitus Audiol Neurotol 2015;20: DOI: /

Estimated chlamydia prevalence after the introduction of the baseline testing uptake scenario for five consecutive years. Estimated chlamydia prevalence.

Johannes Schmid et al. JACC 2018;71:

Figure 4 Example of PK/PD simulation to optimize a vinorelbine treatment regimen Figure 4 | Example of PK/PD simulation to optimize a vinorelbine treatment.

Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight change. Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight.

Krzysztof Narkiewicz et al. BTS 2016;1:

Mean change in patient-reported outcomes from baseline to Week 25 with biweekly or monthly pegloticase compared with placebo. Mean change in patient-reported.

Studies reporting the incident rate for all types of infections per 1000 patient days. Studies reporting the incident rate for all types of infections.

Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.

Study Design Ketil Lunde, et al. N Engl J Med 2006;355:

Daniel J. Lenihan et al. BTS 2016;1:

Dose response of pAGA1 and pFIG1 induction

Volume 151, Issue 3, Pages (March 2017)

Kevin R. King et al. BTS 2016;1:73-86

Fig. 1. Serum HBsAg, HBcrAg, and HBeAg reduction in human patients treated with a single dose of ARC-520. Serum HBsAg, HBcrAg, and HBeAg reduction in human.

Daniel J. Lenihan et al. BTS 2016;1:

Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo.

Heloise Mongue-Din et al. BTS 2017;2:

Colonization with N. musculi results in Ab production.

Daniel J. Lenihan et al. BTS 2016;1:

Helena M. Viola et al. BTS 2018;3:

Helena M. Viola et al. BTS 2018;3:

Helena M. Viola et al. BTS 2018;3:

PPD status of CZP-treated patients with RA in the pooled RA safety database (N=4049) at baseline and TB incidence by INH treatment. †One patient who developed.

Leonard M. Rademakers et al. JACEP 2016;2:

Observed (symbols) and model predicted (lines) dopamine time courses in rats following D-amphetamine administration. Observed (symbols) and model predicted.

Prakash Harikrishnan et al. JACEP 2015;1:

Figure 3 Responder subset (A) Percentage of “responders” (nonprogressing patients) at week 25 after 6 months of treatment; percentage of “responders” in.

POPE-2 Trial design: Patients with moderate to large pericardial effusion after cardiac surgery were randomized to colchicine 2 mg loading dose, then 1.

Krzysztof Narkiewicz et al. BTS 2016;1:

Nat. Rev. Cardiol. doi: /nrcardio

Volume 114, Issue 6, Pages (June 1998)

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Sven Y. Surikow et al. BTS 2018;3:

Romain Gallet et al. BTS 2016;1:14-28

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Figure 1. Changes of Clinical Symptoms Severity in patients on multi-strain probioticFlorasan-D or Placebo Ivashkin V. et al. The Effect of a Multi-strain.

Björn Redfors et al. JACEP 2017;j.jacep

Christopher T. Nguyen et al. BTS 2018;3:97-109

Lauren Brash et al. BTS 2018;3:

(A) Reduction of circulating stromal cell-derived factor (SDF)-1 levels over time in patients with rheumatoid arthritis (RA) and ankylosing spondylitis.

J. Craig Hartman et al. BTS 2018;3:

Nikole J. Byrne et al. BTS 2017;j.jacbts

Figure 1 Annualized percentage brain volume change

Absolute mortality difference Change in LVEF from baseline

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.

Qualitative effects of MPH on the average single neuron response.

Treatment response patterns and effect size over time in exclusively placebo-controlled trials. Treatment response patterns and effect size over time in.

John P. Boehmer et al. JCHF 2017;5:

Mean (SE) maximum urinary uric acid excretion rate (mg/hour) following verinurad doses in combination with febuxostat 40 or 80 mg vs febuxostat 40 or 80 mg.

Cytokine changes in LPS-induced TNFα and spontaneous IL-6 production in whole-blood cultures. Cytokine changes in LPS-induced TNFα and spontaneous IL-6.

Serum bicarbonate increased by ≥3, ≥4, and ≥5 mEq/L in 52%, 39%, and 22% of patients, respectively, in the combined TRC101 dose group compared with 6%,

Achievement of MDA over 144 weeks in patients initially receiving adalimumab or placebo during the double-blind period. Achievement of MDA over 144 weeks.

Mean Pulmonary Artery Pressure Change Post-Thrombectomy Average pre-procedural mean pulmonary artery pressure (mPAP) in patients with pulmonary hypertension.

Mean changes (standard error) from baseline in A1C (A and B) and body weight (C and D) for patients with type 1 (A and C) or type 2 (B and D) diabetes.

Maria R. Costanzo et al. JCHF 2016;4:

David J.A. Jenkins et al. JACC 2018;71:

Michael A. Makara et al. BTS 2018;3:

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

Ruxolitinib for Myelofibrosis–An Update of Its Clinical Effects

PHOENIX I: PASI 75 Response After 12 Weeks

Tremor under amitritptyline.

Heloise Mongue-Din et al. BTS 2017;2:

Baseline characteristics of people who inject drugs enrolled in the Montreal Hepatitis C Cohort (2004–2017), by prescribed dosage of opioid agonist treatment,

Genus-level taxa associated with UCLA-SSc cohort patients versus healthy particiapnts. Genus-level taxa associated with UCLA-SSc cohort patients versus.

Presentation transcript:

Daniel J. Lenihan et al. BTS 2016;1:576-586 Mean Absolute Change in LVEF After Dosing The mean absolute change in LVEF from baseline for the patients in the placebo, pooled low-dose, and high-dose groups are displayed over 90 days. The dashed line represents the high-dose group with cohort 7 (highest dose 1.5 mg/kg, with DLT) data included. Since this dose will no longer be developed clinically, the solid blue line represents the data without this cohort. There was a significant increase in LVEF at 30 days between the high groups compared with placebo (p < 0.01). At 90 days, only the highest dose group showed a significant increase compared with the placebo group (p < 0.01). Abbreviations as in Figures 1 and 2. Daniel J. Lenihan et al. BTS 2016;1:576-586 The Authors